等待开盘 10-08 09:30:00 美东时间
-3.370
-1.20%
今日重点评级关注:Jones Trading:维持Opus Genetics"买入"评级,目标价从10美元升至17美元;Citizens:维持Rezolute"跑赢大市"评级,目标价从11美元升至15美元
10-07 17:30
BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $810 to $826.
10-06 18:07
今日重点评级关注:Canaccord Genuity:维持Aurora Innovation"买入"评级,目标价从15美元升至17美元;摩根大通:维持皇家加勒比邮轮"超配"评级,目标价从345美元升至394美元
09-25 15:55
Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $582 price target.
09-24 17:44
Praxis Precision Medicines granted restricted stock units covering 11,535 shares to 66 new non-executive employees on September 1, 2026, under the 2024 Inducement Plan. The awards vest over four years, contingent on continued employment. The company focuses on CNS disorders and has four late-stage product candidates.
09-03 20:01
今日重点评级关注:摩根士丹利:维持Ultragenyx Pharmaceutical"超配"评级,目标价从67美元升至74美元;Truist Securities:维持Solid Biosciences"买入"评级,目标价从16美元升至20美元
08-24 16:40
Goldman Sachs analyst Kevin Strang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $470 to $575.
08-22 01:52
康耐视小升1.99%;Brookfield基础设施小升1.95%;Gen Digital小升1.93%
08-08 06:10
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41